Peter Attia· MD
right now if you want you could measure dis mool and perhaps use that as a cautionary marker number one if they're not on a drug and it's low you if you haven't done an apoe4 genotype you might look at it
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
right now if you want you could measure dis mool and perhaps use that as a cautionary marker number one if they're not on a drug and it's low you if you haven't done an apoe4 genotype you might look at it
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.